Capnography can be defined as a non-invasive measurement of the partial pressure of carbon dioxide during inspiration and expiration from the airway. It offers physiologic information on metabolism, perfusion, and ventilation, which is crucial for managing the airway.
The usage of capnography is rising in the healthcare for assessment and treatment of patients. It includes verifying and monitoring the ETT position or blind insertion of the airway device. The misplacement of the tube in the esophagus can cause a patient’s death.
The capnography devices industry is projected to rise in the coming years, and generate revenue worth $736.6 million in 2030. It is led by the increasing incidences of respiratory diseases, rising geriatric population, growing technological advancements in capnography devices, and, worldwide increasing government initiatives.
 |
| Get the sample pages of this report: https://bit.ly/42dd21g |
Under the product segment, the multi-parameter capnography devices are predicted to experience the fastest growth in the coming future. It is attributed to the easy integration of these devices into patient monitoring systems for detecting numerous parameters of patients. A few of them can also be utilized in pulse oximeters.
Under the technology segment, the industry is categorized into mainstream and side stream capnography. The mainstream capnography is considered invasive and non-diverting. It means that the ETCO2 is measured at the sample site or airway. Hence, it provides real-time carbon dioxide pressure.
The side-stream-based capnography devices capture a significant share of the capnography devices industry. It is led by their ability to facilitate adequate quantitative bedside information of these devices on uneven alveolar emptying and ventilation-perfusion mismatch. This technology offers no calibration before use and takes significantly less warm-up time to make it usable in emergencies.
Under the component segment, the original equipment manufacturer modules are predicted to experience substantial growth in the coming future in the industry. It is attributed to their ability to monitor carbon dioxide or end-tidal carbon dioxide precisely, even through smaller and portable monitors.
Under the end user segment, hospitals are expected to experience the fastest growth in the capnography device industry in the coming future. It is ascribed to the growing demand for capnography devices in critical care and emergency departments of hospitals.
The MCS, photodetectors, and miniaturized main-stream multi-gas monitors are incorporated into the micro-stream multi-gas monitors. Such advancements lead to precise accuracy and safety levels. It also possesses an adjustable flow rate to enable large sample volume retrieval, and prevent moisture contamination.
In addition, North America captures a significant share of the capnography devices. It is led by the growing incidences of respiratory medical conditions, penetration of key players, enhanced healthcare infrastructure, and increased awareness among healthcare professionals, in the region.
The major companies operating in the industry are:
1- Shenzhen Comen Medical Instruments Co. Ltd.
2- Nonin Medical Inc.
3- Becton
4- Smiths Group plc
5- Welch Allyn Inc.
6- Nihon Kohden Corporation
7- Zoll Medical Corporation
8- Koninklijke Philips N.V.
Therefore, the prominence of capnography devices in the healthcare sector boosts industry growth.
No comments:
Post a Comment